why choose us

First received: March 02, 2023

Clinical Trial: Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Kidney Disease Stage 3

Study Type: INTERVENTIONAL


Official Title: Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease - Randomized, Double-blind, Placebo-controlled Trial

Brief Summary: The Sulforaphane Production System® in Avmacol Extra Strength (ES) supplies broccoli seed extract (glucoraphanin) and Myrosimax® (Active Myrosinase Enzyme) which helps promote sulforaphane production in your body.The investigators hypothesize that daily intake of Avmacol ES can decrease kidney disease progression rate and decrease markers of oxidative stress and inflammation in Chronic Kidney Disease (CKD) patients.They will test this hypothesis in a randomized, double-blind, placebo controlled Phase 2 clinical…

Read more